| Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients MI Restrepo, BL Babu, LF Reyes, JD Chalmers, NJ Soni, O Sibila, ... European Respiratory Journal 52 (2), 2018 | 223 | 2018 |
| The severe asthma network in Italy: findings and perspectives E Heffler, F Blasi, M Latorre, F Menzella, P Paggiaro, G Pelaia, G Senna, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (5), 1462-1468, 2019 | 194 | 2019 |
| Prevalence and etiology of community-acquired pneumonia in immunocompromised patients MF Di Pasquale, G Sotgiu, A Gramegna, D Radovanovic, S Terraneo, ... Clinical Infectious Diseases 68 (9), 1482-1493, 2019 | 189 | 2019 |
| Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma … TW Harrison, P Chanez, F Menzella, GW Canonica, R Louis, BG Cosio, ... The lancet respiratory medicine 9 (3), 260-274, 2021 | 164 | 2021 |
| Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study S Aliberti, LF Reyes, P Faverio, G Sotgiu, S Dore, AH Rodriguez, NJ Soni, ... The Lancet Infectious Diseases 16 (12), 1364-1376, 2016 | 158 | 2016 |
| Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry GW Canonica, GL Colombo, GM Bruno, S Di Matteo, C Martinotti, F Blasi, ... World Allergy Organization Journal 12 (1), 100007, 2019 | 123 | 2019 |
| Noninvasive respiratory support outside the intensive care unit for acute respiratory failure related to coronavirus-19 disease: a systematic review and meta-analysis G Cammarota, T Esposito, D Azzolina, R Cosentini, F Menzella, S Aliberti, ... Critical Care 25, 1-14, 2021 | 87 | 2021 |
| Effectiveness of noninvasive ventilation in COVID‐19 related‐acute respiratory distress syndrome F Menzella, C Barbieri, M Fontana, C Scelfo, C Castagnetti, G Ghidoni, ... The clinical respiratory journal 15 (7), 779-787, 2021 | 87 | 2021 |
| Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: evidences from the Severe Asthma Network Italy (SANI) registry GW Canonica, L Malvezzi, F Blasi, P Paggiaro, M Mantero, G Senna, ... Respiratory Medicine 166, 105947, 2020 | 82 | 2020 |
| One year of mepolizumab. Efficacy and safety in real-life in Italy D Bagnasco, M Caminati, F Menzella, M Milanese, G Rolla, C Lombardi, ... Pulmonary pharmacology & therapeutics 58, 101836, 2019 | 80 | 2019 |
| Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases F Menzella, M Lusuardi, C Galeone, S Taddei, L Zucchi Journal of asthma and allergy, 105-114, 2015 | 78 | 2015 |
| Characteristics and treatment regimens across ERS SHARP severe asthma registries JJMH van Bragt, IM Adcock, EHD Bel, GJ Braunstahl, A Ten Brinke, ... European Respiratory Journal 55 (1), 2020 | 76 | 2020 |
| Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation F Menzella, M Fontana, C Salvarani, M Massari, P Ruggiero, C Scelfo, ... Critical Care 24 (1), 589, 2020 | 75 | 2020 |
| A case of chronic eosinophilic pneumonia in a patient treated with dupilumab F Menzella, G Montanari, G Patricelli, A Cavazza, C Galeone, P Ruggiero, ... Therapeutics and clinical risk management, 869-875, 2019 | 72 | 2019 |
| Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposis GW Canonica, TW Harrison, P Chanez, F Menzella, R Louis, BG Cosio, ... Allergy 77 (1), 150-161, 2022 | 68 | 2022 |
| Pneumonia and invasive pneumococcal diseases: the role of pneumococcal conjugate vaccine in the era of multi-drug resistance C Scelfo, F Menzella, M Fontana, G Ghidoni, C Galeone, NC Facciolongo Vaccines 9 (5), 420, 2021 | 63 | 2021 |
| Asthma in a large COVID-19 cohort: prevalence, features, and determinants of COVID-19 disease severity M Caminati, A Vultaggio, A Matucci, G Senna, F Almerigogna, ... Respiratory Medicine 176, 106261, 2021 | 63 | 2021 |
| Real-life efficacy of omalizumab after 9 years of follow-up F Menzella, C Galeone, D Formisano, C Castagnetti, P Ruggiero, ... Allergy, Asthma & Immunology Research 9 (4), 368-372, 2017 | 63 | 2017 |
| Tailored therapy for severe asthma F Menzella, M Lusuardi, C Galeone, L Zucchi Multidisciplinary respiratory medicine 10, 1-8, 2015 | 59 | 2015 |
| Long-term benefits of omalizumab in a patient with severe non-allergic asthma F Menzella, R Piro, N Facciolongo, C Castagnetti, A Simonazzi, L Zucchi Allergy, Asthma & Clinical Immunology 7, 1-4, 2011 | 58 | 2011 |
carla galeoneAzienda USL-IRCCS of Reggio Emiliaبريد إلكتروني تم التحقق منه على ausl.re.it
